Daclatasvir/ribavirin/sofosbuvirLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1950卷 / 1期

关键词：

D O I：

10.1007/s40278-023-36545-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：148 / 148

相关论文

共 50 条

[21] Daclatasvir/sofosbuvirPruritus: case report
Reactions Weekly, 2018, 1701 (1) : 108 - 108
[22] Daclatasvir/oxcarbazepine interactionDecreased plasma concentration of daclatasvir: case report
Reactions Weekly, 2017, 1649 (1) : 88 - 88
[23] Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation
Fontana, Robert J.
Hughes, Eric A.
Appelman, Henry
Hindes, Robert
Dimitrova, Dessislava
Bifano, Marc
LIVER TRANSPLANTATION, 2012, 18 (09) : 1053 - 1059
[24] Daclatasvir/ribavirin/sofosbuvirAnaemia, death and recurrent hypoglycaemia: 3 case reports
Reactions Weekly, 2018, 1707 (1) : 107 - 107
[25] Daclatasvir/sofosbuvir/ribavirinAnaemia: case report
Reactions Weekly, 2017, 1640 (1) : 121 - 121
[26] Daclatasvir/sofosbuvirAllergic reaction: case report
Reactions Weekly, 2022, 1935 (1) : 172 - 172
[27] Daclatasvir/sofosbuvirCerebral haemorrhage: case report
Reactions Weekly, 2017, 1640 (1) : 120 - 120
[28] Daclatasvir/sofosbuvirTreatment failure: case report
Reactions Weekly, 2023, 1954 (1) : 174 - 174
[29] Daclatasvir/simeprevirHepatic encephalopathy: case report
Reactions Weekly, 2016, 1629 (1) : 96 - 96
[30] Daclatasvir/sofosbuvirLiver injury: case report
Reactions Weekly, 2017, 1633 (1) : 251 - 251

← 1 2 3 4 5 →